Sign in / Join Now
ETFs & Funds
Jim Van Meerten
- 100% Barchart technical buy signal - 5 new highs and up 27.51% in the last month - Relative Strength Index 72.31%
Add a reply...
Latest StockTalks »
people get RPRX breaking news and analysis by email alert.
Get email alerts on RPRX »
Repros Therapeutics Inc.
Get latest price
From other sites
Repros Announces Submission Of MAA To The European Medicines Agency For Enclomiphene In The Treatment Of Secondary Hypogonadism
at TheStreet (Sep 12, 2016)
Repros Therapeutics' (RPRX) Proellex Positive in Phase II
at Zacks.com (Sep 8, 2016)
Repros Provides Phase 2 Results Showing Positive Outcomes For Oral Proellex® In Women With Moderate To Severe Endometriosis
at TheStreet (Sep 7, 2016)
Repros Provides Six Month Interim Results For Enclomiphene Study In Obese Secondary Hypogonadal Men
at TheStreet (Aug 15, 2016)
Repros Therapeutics Inc.® Reports Second Quarter 2016 Financial Results
at TheStreet (Aug 9, 2016)